Maxcyte (MXCT) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.30, +4.00% vs the prior close of $1.25.
- Volume 3.79M shares, 4.8x its 50-day average (heavy).
- New SEC filings: SCHEDULE 13D (Oct 15, 2026), 8-K (Oct 14, 2026).
- No new insider buys or sales reported since the prior session.
MXCT jumps 4.0% to $1.30, a 1-month high on 4.8x normal volume. Closed at $1.30, +4.00% vs the prior close of $1.25. Day range $1.25–$1.31, opened at $1.27.
MXCT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MXCT jumps 4.0% to $1.30, a 1-month high on 4.8x normal volume
- Closed at $1.30, +4.00% vs the prior close of $1.25. Day range $1.25–$1.31, opened at $1.27.
- Volume was 3.79M shares, 4.8x its 50-day average of 793.76K — unusually heavy trading.
- Price is +7.4% vs its 50-day average ($1.21) and +22.5% vs its 200-day average ($1.06).
- 52-week range $0.64–$1.87; today's close sits at 54% of that range, 30.3% below the 52-week high.
Oct 14, 2026 — MXCT jumps 29.7% to $1.25, a 1-month high on 23.2x normal volume
- Closed at $1.25, +29.67% vs the prior close of $0.96. Day range $1.20–$1.33, opened at $1.23.
- Volume was 12.67M shares, 23.2x its 50-day average of 546.75K — unusually heavy trading.
- Price is +3.7% vs its 50-day average ($1.21) and +17.6% vs its 200-day average ($1.06).
- 52-week range $0.64–$1.87; today's close sits at 50% of that range, 33.0% below the 52-week high.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 13, 2026 — MXCT slides 3.1% to $0.96, a 3-month low, 5 down days in a row
- Closed at $0.96, -3.12% vs the prior close of $1.00. Day range $0.94–$1.01, opened at $0.98.
- Volume was 327.90K shares, 0.6x its 50-day average of 547.68K — lighter than usual.
- Price is -19.8% vs its 50-day average ($1.20) and -9.4% vs its 200-day average ($1.06).
- 52-week range $0.64–$1.87; today's close sits at 26% of that range, 48.3% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — MXCT dips 1.5% to $1.00, a 3-month low, 4 down days in a row
- Closed at $1.00, -1.49% vs the prior close of $1.01. Day range $0.97–$1.01, opened at $1.01.
- Volume was 150.00K shares, 0.3x its 50-day average of 554.25K — lighter than usual.
- Price is -17.4% vs its 50-day average ($1.20) and -6.8% vs its 200-day average ($1.07).
- 52-week range $0.64–$1.87; today's close sits at 29% of that range, 46.6% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — MXCT dips 1.0% to $1.01, a 1-month low, 3 down days in a row
- Closed at $1.01, -0.98% vs the prior close of $1.02. Day range $0.99–$1.03, opened at $1.02.
- Volume was 240.00K shares, 0.4x its 50-day average of 555.66K — lighter than usual.
- Price is -16.2% vs its 50-day average ($1.21) and -5.6% vs its 200-day average ($1.07).
- 52-week range $0.64–$1.87; today's close sits at 30% of that range, 45.8% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — MXCT dips 1.9% to $1.02, a 1-month low
- Closed at $1.02, -1.92% vs the prior close of $1.04. Day range $0.96–$1.04, opened at $1.04.
- Volume was 476.80K shares, 0.8x its 50-day average of 562.29K.
- Price is -15.5% vs its 50-day average ($1.21) and -5.0% vs its 200-day average ($1.07).
- 52-week range $0.64–$1.87; today's close sits at 31% of that range, 45.3% below the 52-week high.
Oct 7, 2026 — MXCT slides 4.6% to $1.04, a 1-month low
- Closed at $1.04, -4.59% vs the prior close of $1.09. Day range $1.04–$1.08, opened at $1.07.
- Volume was 311.90K shares, 0.5x its 50-day average of 587.91K — lighter than usual.
- Price is -13.8% vs its 50-day average ($1.21) and -3.3% vs its 200-day average ($1.08).
- 52-week range $0.64–$1.87; today's close sits at 32% of that range, 44.2% below the 52-week high.
Oct 6, 2026 — MXCT rises 0.9% to $1.09
- Closed at $1.09, +0.93% vs the prior close of $1.08. Day range $1.05–$1.11, opened at $1.09.
- Volume was 333.10K shares, 0.5x its 50-day average of 607.22K — lighter than usual.
- Price is -9.7% vs its 50-day average ($1.21) and +1.1% vs its 200-day average ($1.08).
- 52-week range $0.64–$1.87; today's close sits at 37% of that range, 41.6% below the 52-week high.
Oct 5, 2026 — MXCT rises 0.9% to $1.08
- Closed at $1.08, +0.93% vs the prior close of $1.07. Day range $1.06–$1.10, opened at $1.08.
- Volume was 194.90K shares, 0.3x its 50-day average of 613.41K — lighter than usual.
- Price is -10.4% vs its 50-day average ($1.21) and -0.0% vs its 200-day average ($1.08).
- 52-week range $0.64–$1.87; today's close sits at 36% of that range, 42.1% below the 52-week high.
Oct 2, 2026 — MXCT dips 1.8% to $1.07, a 1-month low, 3 down days in a row
- Closed at $1.07, -1.83% vs the prior close of $1.09. Day range $1.07–$1.11, opened at $1.11.
- Volume was 228.10K shares, 0.4x its 50-day average of 619.52K — lighter than usual.
- Price is -11.2% vs its 50-day average ($1.21) and -1.1% vs its 200-day average ($1.08).
- 52-week range $0.64–$1.87; today's close sits at 35% of that range, 42.6% below the 52-week high.
- That makes 3 straight losses.
MXCT latest news & SEC filings
Every SEC filing by or about MXCT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $4.94M (prior year $5.82M) (-15.2% vs Jun 30, 2025)
- Net income: -$8.87M (prior year -$12.36M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.08 (prior year -$0.12) (loss narrowed vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 4, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade MXCT
- Last results release: Oct 14, 2026 (8-K Item 2.02). Previous ones: Aug 12, 2026, May 12, 2026, Mar 24, 2026. Based on that rhythm, the next report is likely around Jan 13, 2027 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.50% (largest 29.7%). That is a volatile stock.
- Liquidity: about 1.12M shares (≈$1.46M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.30 vs a range of $0.64–$1.87 (54% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 1 sales; latest: Douglas J Swirsky sold 10,142 shares on Mar 17, 2026.
- Latest filings: 8-K Oct 14, 2026; 10-Q Aug 13, 2026; 8-K Aug 12, 2026.
- Share count: 103.21M shares outstanding (Aug 7, 2026), -3.2% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Services-Commercial Physical & Biological Research.
MXCT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 1.27 | 1.31 | 1.25 | 1.30 | 3.79M |
| Oct 14, 2026 | 1.23 | 1.33 | 1.20 | 1.25 | 12.67M |
| Oct 13, 2026 | 0.98 | 1.01 | 0.94 | 0.96 | 327.90K |
| Oct 12, 2026 | 1.01 | 1.01 | 0.97 | 1.00 | 150.00K |
| Oct 9, 2026 | 1.02 | 1.03 | 0.99 | 1.01 | 240.00K |
| Oct 8, 2026 | 1.04 | 1.04 | 0.96 | 1.02 | 476.80K |
| Oct 7, 2026 | 1.07 | 1.08 | 1.04 | 1.04 | 311.90K |
| Oct 6, 2026 | 1.09 | 1.11 | 1.05 | 1.09 | 333.10K |
| Oct 5, 2026 | 1.08 | 1.10 | 1.06 | 1.08 | 194.90K |
| Oct 2, 2026 | 1.11 | 1.11 | 1.07 | 1.07 | 228.10K |
| Oct 1, 2026 | 1.12 | 1.16 | 1.08 | 1.09 | 397.10K |
| Sep 30, 2026 | 1.19 | 1.20 | 1.12 | 1.12 | 346.50K |
| Sep 29, 2026 | 1.18 | 1.23 | 1.16 | 1.18 | 542.90K |
| Sep 28, 2026 | 1.16 | 1.17 | 1.14 | 1.16 | 284.70K |
| Sep 25, 2026 | 1.20 | 1.20 | 1.16 | 1.17 | 415.90K |
| Sep 24, 2026 | 1.19 | 1.21 | 1.17 | 1.19 | 231.70K |
| Sep 23, 2026 | 1.24 | 1.24 | 1.19 | 1.19 | 251.70K |
| Sep 22, 2026 | 1.22 | 1.25 | 1.20 | 1.24 | 259.70K |
| Sep 21, 2026 | 1.19 | 1.24 | 1.18 | 1.22 | 471.80K |
| Sep 18, 2026 | 1.19 | 1.21 | 1.16 | 1.19 | 485.20K |
About Maxcyte
Maxcyte (MXCT) is listed on the Nasdaq and classified by the SEC under “Services-Commercial Physical & Biological Research”. Its business address is in ROCKVILLE, MD. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1287098.
MXCT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Yasir B. Al-Wakeel | Director | Jun 22, 2026 |
| Patrick J Balthrop | Director | Jun 22, 2026 |
| William W Brooke | Director | Jun 22, 2026 |
| Cynthia Collins | Director | Jun 22, 2026 |
| Richard Douglas | Director | Jun 22, 2026 |
| Stanley C Erck | Director | Jun 22, 2026 |
| Rekha Hemrajani | Director | Jun 22, 2026 |
| John Joseph Johnston | Director | Jun 22, 2026 |
| Maher Masoud | President and CEO | Mar 31, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Parmeet Ahuja | Chief Financial Officer | Apr 17, 2026 |
| Maher Masoud | President and CEO | Mar 31, 2026 |
| Douglas J Swirsky | CHIEF FINANCIAL OFFICER | Mar 19, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 17, 2026 | Douglas J Swirsky | Sale | 10,142 | $0.82 |
MXCT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $20.96M | $-44.63M | -0.42 | $-34.41M |
| Dec 31, 2024 | $22.21M | $-41.05M | -0.39 | $-27.61M |
| Dec 31, 2023 | $19.50M | $-37.92M | -0.37 | $-21.69M |
| Dec 31, 2022 | $28.75M | $-23.57M | -0.23 | $-14.78M |
| Dec 31, 2021 | $21.57M | $-19.08M | -0.21 | $-10.68M |
Latest balance sheet: total assets $184.67M, total liabilities $25.92M, cash $15.04M (as of Jun 30, 2026).
MXCT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 14, 2026 | 8-K Item 2.02 (results) | $1.25 |
| Aug 12, 2026 | 8-K Item 2.02 (results) | $1.27 |
| May 12, 2026 | 8-K Item 2.02 (results) | $0.82 |
| Mar 24, 2026 | 8-K Item 2.02 (results) | $0.74 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $1.36 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $1.58 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $1.67 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $2.04 |
| May 7, 2025 | 8-K Item 2.02 (results) | $2.74 |
| Mar 11, 2025 | 8-K Item 2.02 (results) | $3.47 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $4.91 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $3.88 |
Related stocks · Services-Commercial Physical & Biological Research
Iqvia (IQV)Charles River Laboratories International (CRL)Incyte (INCY)Medpace (MEDP)Icon (ICLR)Absci (ABSI)bioAffinity Technologies (BIAF)OmniAb (OABI)Nrc Health (NRC)OneMedNet (ONMD)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)AMD (AMD)Apple (AAPL)Tesla (TSLA)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MXCT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.